EGFR T790M detection in TKI-naive NSCLCs carrying sensitive EGFR mutations

被引：0

作者：

Pinotti, G. ^{[1
]}

Cerutti, R. ^{[2
]}

Sahnane, N. ^{[2
]}

Lettig, L. ^{[2
]}

Albeni, C. ^{[2
]}

Tuzi, A. ^{[1
]}

Franzi, F. ^{[2
]}

Pastore, A. ^{[1
]}

Ogliari, F. ^{[1
]}

Sessa, F. ^{[2
]}

Furlan, D. ^{[2
]}

机构：

[1] Osped Circolo Varese, Oncol, Fdn Macchi, Varese, Italy

[2] Univ Insubria, Osped Circolo, Dept Med & Surg, Varese, Italy

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1335P

引用

页数：1

共 50 条

[41] In silico insight into EGFR treatment in patients with lung carcinoma and T790M mutations [J].

Zang, Shu-Zhi ;

Yang, Yan-Rong ;

Zhao, Sha-Sha ;

Li, Yun-Xia ;

Gao, Xin-Yuan ;

Zhong, Chun-Lei .

EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (05) :1735-1740

[42] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI [J].

Ren, Shengxiang ;

Li, Wei ;

Li, Aiwu ;

Chen, Xiaoxia ;

Gao, Guanghui ;

He, Yayi ;

Li, Xuefei ;

Zhou, Caicun .

JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S1084-S1084

[43] Tissue Is the Issue for Diagnosis of EGFR T790M Mutation [J].

Khan, Jenna ;

Pritchard, Colin C. ;

Martins, Renato G. .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) :E91-E92

[44] Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC [J].

Mohorcic, K. ;

Janzic, A. ;

Janzic, U. ;

Rot, M. ;

Kern, I. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S557-S558

[45] Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI Resistance [J].

Zhang, Yidan ;

Xu, Yingqi ;

Xu, Jianlin ;

Zhong, Hua ;

Xia, Jinjing ;

Zhong, Runbo .

CANCER SCIENCE, 2024, :753-763

[46] EGFR T790M co-exists with sensitive mutations in the same cell group in lung adenocarcinoma patients [J].

Shi, X. ;

Wu, S. ;

Wang, H. ;

Liang, Z. ;

Zeng, X. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) :S92-S92

[47] Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M [J].

Senoo, Satoru ;

Ohashi, Kadoaki ;

Nishii, Kazuya ;

Hara, Naofumi ;

Kano, Hirohisa ;

Ninomiya, Kiichiro ;

Maeda, Yoshinobu ;

Kiura, Katsuyuki .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) :E140-E142

[48] Detection of EGFR/T790M Mutation in Advanced NSCLC Post TKI Treatment: First Experience of Liquid Biopsy in Argentina [J].

Mosqueira, M. C. ;

Anchordoqui, S. ;

Martinez Correa, R. ;

Pichelbauer, E. ;

Trinchero, A. ;

Bianchini, M. ;

Bravo, I. ;

Bramuglia, G. ;

Diaz Perez, I. ;

Sganga, L. ;

Goncalves, S. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) :S166-S167

[49] Highly sensitive and quantitative detection of EGFR T790M mutationin tumor samples by nanofluidic digital PCR [J].

Iwama, Eiji ;

Takayama, Koichi ;

Harada, Taishi ;

Okamoto, Isamu ;

Baba, Eishi ;

Oda, Yoshinao ;

Nakanishi, Yoichi .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[50] Correlation between re-biopsy site and detection of T790M mutation in NSCLC patients treated with EGFR TKI [J].

Shigematsu, Fumie ;

Kogure, Yoshihito ;

Saka, Hideo ;

Yamada, Arisa ;

Ishida, Akane ;

Ise, Yuko ;

Hori, Kazumi ;

Oka, Saori ;

Nakahata, Masashi ;

Kitagawa, Chiyoe ;

Oki, Masahide .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →